Patient’s Roadmap Through Myelofibrosis and Anemia
Living with myelofibrosis often feels like a real-life rollercoaster, with steep highs and crashing lows that change in an instant. Patients frequently describe the experience of managing fear as a matter of taking control over their expectations rather than the disease itself. For those handling the associated anemia and fatigue, connecting with others who share the same rare condition can provide a necessary sense of stability in an otherwise isolating experience.
Tracy emphasizes the emotional toll of feeling alone with a rare diagnosis. “I wish somebody would have told me that I’m not alone in this. It’s huge to know someone else with the same rare condition because it feels very isolating at times,” she said. Sharon faces similar challenges. Diagnosed with essential thrombocythemia at age 16, she has watched her condition progress through polycythemia vera to myelofibrosis. She relies on a combination of rest and activity to manage her fatigue, but she often feels frustrated by a lack of awareness from the medical community. “It’s really challenging living with a cancer that’s not well known and not very visible,” she said. “I am often exhausted; I have been hospitalized so many times for related complications. But still, some of the closest people in my life wonder if it’s all exaggerated if I overreact to how bad I’m feeling.”
Related: FDA Approves First Essential Thrombocythemia Drug in Nearly 30 Years
Ignacio spent nearly three years receiving incorrect diagnoses before his MF was properly identified. He advises others to be their own advocates, particularly when dealing with emergency care teams. “You need to be able to explain to ER/urgent care teams what you have and what you’re feeling,” he said. “I actually had a doctor say: ‘Give me a minute to Google this.'”
One consistent theme among patients is the need for an MPN specialist. These doctors see a higher volume of MF patients than general hematologists, which often leads to more accurate diagnostic testing, including bone marrow biopsies. Patients who struggle to find such specialists should consider seeking a second opinion to ensure their care team is fully aware of their disease state and potential treatment options.
Related: Sarclisa Subcutaneous Option Offers Hope to Myeloma Patients
Weighing Transplant Options
Stem cell transplantation remains the only potential cure for myelofibrosis, but the decision to undergo the procedure is complex and carries significant physical and emotional weight. Information about transplants can be misrepresented when physicians are not as up to date on new non-transplant options for the few MF patients they may treat. I have heard from people living with low-risk MF without bothersome constitutional symptoms who struggle with this decision. In the past, the transplant was frequently presented as the standard solution, but the setting has shifted. With steady advances in treatments focused on anemia and symptom relief, many patients are now able to manage their condition with medication rather than undergoing a high-risk procedure.
This shift represents a significant change in how the disease is approached, allowing for a wider range of therapeutic choices that prioritize quality of life alongside survival.
Related: Pain relief through self help is highly effective
Taking Action
Patients looking to handle their journey more effectively should focus on a few key steps. Securing care from a specialist who treats a large number of MF patients is critical. These providers have a deeper understanding of the disease and are more likely to be up to date on the latest options for managing anemia and fatigue. If a specialist is not available, coordinating with a general hematologist or oncologist can help bridge the gap.
